D345 Psychopharmacology for Advanced Psychiatric Mental Health Practice, catalog number NURS 6348, is the three-CU prescribing course in the WGU PMHNP track. It covers advanced pharmacotherapeutics for safely prescribing the agents used to manage chronic and acute mental health problems across diverse populations. It is the course where the specialty stops being conceptual, and the written work is scored on whether your prescribing rationale would survive being read by a pharmacist.
What NURS 6348 is actually testing
Psychopharmacology sits apart from the pharmacology of other specialties for three reasons, and all three show up in scoring.
The first is latency. Most psychiatric agents do not produce their intended effect quickly, while side effects usually arrive immediately. That inverts the usual risk-benefit conversation and makes the first weeks of treatment the period when patients stop. A prescribing plan that does not address the gap between when harm appears and when benefit appears has not engaged with the pharmacology.
The second is that the target is subjective. There is no blood level that tells you depression has lifted. Response is measured with rating scales, function and report, which means a prescribing plan needs a stated way of measuring whether it worked, at a stated interval, before it starts.
The third is the interaction burden. Psychiatric patients frequently take several agents, often from more than one prescriber, alongside substances that are rarely disclosed at first. Metabolic pathway interactions, additive sedation, serotonergic load, QT effects and withdrawal syndromes are all live concerns, and a written plan that names an agent without checking the existing list is incomplete.
Beyond those three, the course tests the reasoning behind the choice. Two agents can be equally reasonable for the same diagnosis, and the defensible answer names why this agent for this person: comorbidity, side effect profile matched to what the patient can tolerate, cost, previous response, family history of response, pregnancy status, or the risk in overdose.
Turning scored aspects into a section plan
The rubric lives in your Course of Study rather than the catalog, so open it and count the aspects first. Each is scored independently against a three-point scale and each needs a 2. In a prescribing course this bites hard: a superb mechanism section does not compensate for a monitoring section that says check labs periodically.
The word budget, worked. Suppose eight scored aspects and directions calling for about 2,400 words. Set aside 140 for a case summary and 110 for a close, leaving 2,150 across eight aspects, or about 269 each. Then weight for content density. The mechanism aspect needs 350 to cover receptor action and its link to the target symptoms. The monitoring aspect needs 340, since baseline, interval and threshold all live there. That is 690 for two, leaving 1,460 for six at about 243 each.
Before writing, build a small internal table for yourself: agent, class, mechanism, expected onset, main adverse effects, monitoring, interactions, and the reason for choosing it. Every one of those columns will be a sentence somewhere in the paper, and an empty cell is a hole an evaluator will find.
A structure that fits a psychopharmacology write-up
Task directions govern where they specify a format. Where they do not, this arrangement carries a prescribing argument cleanly.
| Section | What belongs in it | What earns the aspect |
|---|---|---|
| Case and diagnosis | De-identified presentation, working diagnosis, current medications and substances | A full existing medication list, because interactions cannot be assessed without one |
| Treatment target | The specific symptoms the medication is meant to change | Named target symptoms rather than a diagnosis label |
| Agent selected | Generic name, class, and the reason this agent for this person | A reason tied to the individual, not to the diagnosis alone |
| Mechanism | Receptor, transporter or enzyme action and how it connects to the target symptoms | Mechanism linked to symptom, not recited in isolation |
| Dosing and titration | Starting dose, titration steps, expected time to response, maximum | A schedule with intervals, and a stated expectation of when to judge response |
| Adverse effects | Common early effects, serious rare effects, and what the patient is told about each | Early effects addressed, since they are what drives discontinuation |
| Monitoring | Baseline measures, repeat intervals, and the value that would trigger action | A threshold; monitoring without a trigger is not monitoring |
| Interactions and cautions | Pathway interactions, additive effects, population-specific cautions | Checked against the actual medication list in the case |
| Response and next step | How response is measured, and the plan if there is none | A named measure and a stated decision point |
| References | APA list of prescribing information, guidelines and pharmacology sources | Current editions cited to their issuing bodies |
Where your directions ask for doses, show them precisely and consistently. Where they do not, the reasoning still has to be specific enough that a reader could reconstruct the plan.
Evidence craft in psychopharmacology writing
This is a high-stakes sourcing area, and the standard is closer to prescribing practice than to essay writing.
- Cite the prescribing information for drug-specific facts and the guideline for treatment sequence. They answer different questions and evaluators expect both.
- Keep editions current. Psychiatric prescribing guidance and safety communications change, and an outdated source on a safety point is a serious weakness rather than a formatting one.
- Use generic names throughout. Brand names vary by market and mixing them creates ambiguity in a document about safety.
- State the population a trial was conducted in. Efficacy demonstrated in adults does not transfer automatically to adolescents or to older adults, and pretending otherwise is the error the course is built to prevent.
- Report effect honestly. Many psychiatric agents have modest average effects with wide individual variation, and a paper that presents a drug as reliably effective has misread its evidence.
- Quote almost nothing. Prescribing information is heavily reproduced text and WGU runs submissions through a similarity check.
The habit that most improves prescribing writing is naming the discontinuation plan at the same time as the start. How long the trial runs before you judge it, what you do if there is partial response, how the agent would be stopped if it fails, and which agents cannot be stopped abruptly. Prescribing that only plans the beginning is the pattern that produces patients on five medications nobody remembers starting.
What separates Competent from a submission sent back
Aspects score on their own, and monitoring is the aspect most often returned in this course.
- Every monitoring parameter has a baseline, an interval and a threshold that triggers action.
- The agent choice is justified by something about this patient, not only by the diagnosis.
- The full existing medication and substance list is checked against the new agent.
- Time to expected response is stated, and the early adverse effect window is addressed in patient education.
- The plan includes what happens if the agent does not work.
Performance assessment work at WGU can be revised and resubmitted with no grade penalty, so a return costs schedule rather than standing. Schedule is tight in the PMHNP track because the population care courses and internships sit behind this one. Terms are six months at a flat rate, so a course that runs long here usually costs a course somewhere else in the same term.
Six mistakes that cost time in D345
- Prescribing to a diagnosis rather than to symptoms. Two patients with the same diagnosis and different target symptoms often need different agents, and the reasoning aspect wants that shown.
- Monitoring with no threshold. Checking a value periodically tells nobody what to do with the result.
- Ignoring the first two weeks. That is when side effects arrive and benefit has not, and it is when patients stop.
- Treating interactions as a formality. Metabolic pathways, additive sedation and serotonergic load are the reason this course exists.
- Skipping the population caution. Pregnancy, older adults, adolescents, hepatic and renal impairment each change the calculation and are frequently scored.
- No exit plan. A prescribing plan with no stopping criteria and no discontinuation strategy is incomplete on its face.
How support works on this course
D345 is the course where PMHNP students most often ask for help, and the help that works is structural rather than substitutive. Send the rubric from your Course of Study with the task directions and you get a prescribing write-up organised so every scored aspect has its own home, the mechanism tied explicitly to the target symptoms, a monitoring section with baselines, intervals and thresholds, an interaction check against the case's real medication list, and current sources located and cited to their issuing bodies.
Boundaries do not move. Objective assessments at WGU are proctored, so we prepare only, never sit them, and never ask for portal credentials. On field-based courses we never complete clinical hours, contact preceptors or sites, sign placement paperwork or fill in hour logs. Nothing here is clinical advice for a real patient; it is coursework support against a rubric.
Questions students ask about D345
Is D345 the same course as NURS 6348?
How is D345 different from the general advanced pharmacology course?
How much of this course is memorisation?
Writing a prescribing rationale for D345?
Send your Course of Study rubric and the task directions. You get mechanism tied to target symptoms, monitoring with real thresholds, and a full interaction check.
Where D345 sits in WGU's programs
The July 2026 catalog places this code in 2 current WGU programs. Open a program page for the complete standard path and term positions. The live Degree Plan remains authoritative after transfer credit, substitutions, and mentor planning.
The assessments, one by one
The public catalog does not publish this course's PA/OA identity or task count. WGU Tutors publishes at most one PA manual per course and only from a WGU-controlled public rubric. Until that source exists, PA help begins from the student's real Course of Study and OA support remains preparation only.